These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28852496)

  • 1. Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes.
    Cohen JB; Eddinger KC; Shelton B; Locke JE; Forde KA; Sawinski D
    Clin Kidney J; 2017 Aug; 10(4):564-572. PubMed ID: 28852496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
    Potluri VS; Goldberg DS; Mohan S; Bloom RD; Sawinski D; Abt PL; Blumberg EA; Parikh CR; Sharpe J; Reddy KR; Molnar MZ; Sise M; Reese PP
    J Am Soc Nephrol; 2019 Oct; 30(10):1939-1951. PubMed ID: 31515244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
    Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
    JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes?
    Sureshkumar KK; Thai NL; Marcus RJ
    Transplant Proc; 2012 Jun; 44(5):1262-4. PubMed ID: 22663997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes After Direct-Acting Antiviral Therapy Based on Donor Hepatitis C Serostatus Among Hepatitis C Virus-Infected Kidney Transplant Recipients.
    Sedki M; Cortesi C; O'Brien C; Levy C; Martin P; Roth D; Bhamidimarri KR
    Exp Clin Transplant; 2020 Mar; ():. PubMed ID: 32133941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients.
    Miguel M; Sampaio MS; Kuo HT; Poommipanit N; Martin P; Bunnapradist S
    Transplantation; 2010 Jul; 90(1):61-7. PubMed ID: 20463638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.
    Okino K; Okushi Y; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Dec; 21(6):1113-1123. PubMed ID: 28357506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States.
    Yuan Q; Hong S; Leya G; Roth E; Tsoulfas G; Williams WW; Madsen JC; Elias N
    World J Transplant; 2023 Feb; 13(2):44-57. PubMed ID: 36908306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.
    Sise ME; Chute DF; Gustafson JL; Wojciechowski D; Elias N; Chung RT; Williams WW
    Hemodial Int; 2018 Apr; 22 Suppl 1():S71-S80. PubMed ID: 29694722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.
    Cosio FG; Sedmak DD; Henry ML; Al Haddad C; Falkenhain ME; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM
    Transplantation; 1996 Oct; 62(8):1054-9. PubMed ID: 8900300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of opportunistic viral infections in hepatitis C virus nucleic acid test negative recipients of kidneys from hepatitis C virus nucleic acid test positive donors.
    Shah K; Katz-Greenberg G; Steinbrink J; Crona L; Erkanli A; Lee HJ; Yang C; Byrns J
    Transpl Infect Dis; 2024 Oct; 26(5):e14364. PubMed ID: 39185753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.